Major, Jacqueline M <br/><br/>
The Effect of FDA Drug Safety Communications on Patterns of Tiotropium Dispensing: A U.S. Health Plan Claims Database Study.  [electronic resource] 

 -  Journal of managed care & specialty pharmacy  Jul 2018 
 - 700-709 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2376-1032 
<br/><br/><label>Standard No.: </label>10.18553/jmcp.2018.24.7.700  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Administrative Claims, Healthcare--statistics & numerical data<br/>Adrenergic beta-2 Receptor Agonists--therapeutic use<br/>Adult<br/>Aged<br/>Bronchodilator Agents--adverse effects<br/>Drug Prescriptions--statistics & numerical data<br/>Drug Substitution--statistics & numerical data<br/>Drug Therapy, Combination--methods<br/>Female<br/>Health Communication<br/>Humans<br/>Interrupted Time Series Analysis<br/>Male<br/>Middle Aged<br/>Pulmonary Disease, Chronic Obstructive--drug therapy<br/>Stroke--chemically induced<br/>Tiotropium Bromide--adverse effects<br/>United States<br/>United States Food and Drug Administration--organization & administration